SUNDAY ADEYEYE: Open Payments
NPI 1649754292 · SAN BERNARDINO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,232 in 50 payments from 11 companies in 2025. Trend: 2023 $2,625 · 2024 $703 · 2025 $1,232
Food & beverage: $1,133Education: $99
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 17 | $480 |
| Otsuka America Pharmaceutical, Inc. | 10 | $216 |
| E.R. Squibb & Sons, L.L.C. | 10 | $213 |
| Alkermes, Inc. | 3 | $69 |
| Janssen Pharmaceuticals, Inc | 2 | $54 |
| Lundbeck LLC | 2 | $50 |
| Almatica Pharma LLC | 2 | $39 |
| Sage Therapeutics, LLC | 1 | $31 |
| Supernus Pharmaceuticals, Inc. | 1 | $31 |
| Neurocrine BioSciences, Inc. | 1 | $30 |
Products named: AUSTEDO XR, COBENFY, ABILIFY ASIMTUFII, UZEDY, REXULTI, INVEGA SUSTENNA, ARISTADA, LOREEV XR.
Industry payments across CA — which companies pay providers there.
